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794Inﬂammation-related induction of absent
in melanoma 2 (AIM2) in vascular cells and
atherosclerotic lesions suggests a role in vascular
pathogenesis
Maani Hakimi, MD, Andreas Peters, MD, Anja Becker, Dittmar Böckler, MD, and
Susanne Dihlmann, PhD, Heidelberg, Germany
Background: Absent in melanoma (AIM2) was recently identiﬁed to act as a cytosolic DNA sensor in innate immunity.
Considering the role of chronic inﬂammation in atherosclerosis, we hypothesized that AIM2 may act as a damage signal
that is activated in response to cellular stress likewise in vascular cells of larger arteries. We thus addressed AIM2
expression in healthy arterial wall and in different vascular lesions. In addition, AIM2 expression was characterized in
cultured human aortic endothelial cells (HAoECs), smooth muscle cells (HAoSMCs), and T/G-HA-vascular smooth
muscle cells (VSMCs) in response to different stimuli.
Methods: Carotid and aortic lesions from patients who underwent surgery and normal arterial specimens were analyzed by
immunohistochemistry for AIM2 expression. Cultured HAoECs, HAoSMCs, and T/G-HA-VSMCs were stimulated
in vitro with proinﬂammatory cytokines (tumor necrosis factor-a, interferon-g) or poly(dA:dT) and analyzed for AIM2
transcript and protein expression.
Results: AIM2 was detected in ECs of the intima and vasa vasorum of normal carotid artery and aorta. Moreover, AIM2
was moderately expressed in VSMCs of normal media and intima layers, as well as in VSMCs of atherosclerotic lesions.
Increased AIM2 expression was detected around the necrotic core of atherosclerotic carotid lesions and in the vasa
vasorum neovasculature of aortic aneurysms. Subsequent in vitro analysis identiﬁed an endogenous AIM2 expression in
cultured HAoECs, HAoSMCs, and T/G-HA-VSMCs that was markedly increased upon treatment of the cells with
tumor necrosis factor-a, interferon-g, or cytosolic DNA.
Conclusions: ECs and VSMC are able to respond to inﬂammatory signals by upregulation of AIM2 expression, indicating
a role of AIM2 in vascular pathogenesis. (J Vasc Surg 2014;59:794-803.)
Clinical Relevance: This study revealed a prominent role of the interferon-geinducible double-stranded DNA sensor
absent in melanoma (AIM2) in vascular inﬂammation. Immunohistochemical analysis suggested increased AIM2
expression in smooth muscle cells of atherosclerotic carotid lesions and the vasa vasorum of abdominal aortic aneurysms.
In vitro stimulation of aortic endothelial cells and smooth muscle cells by inﬂammatory cytokines and double-stranded
DNA dramatically increased AIM2 expression, which indicates a role of AIM2 in response to inﬂammatory signals in
these cells. These ﬁndings provide new insight on the molecular mechanisms of vascular inﬂammation beyond the role of
AIM2 in macrophages and thus widen the range of putative prognostic and therapeutic targets in vascular pathogenesis.According to current concepts, atherosclerosis is con- evidence suggests a role of the innate immune system
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Macrophages, inﬁltrating early atherosclerotic lesions,
were shown to release interleukin (IL)-1b upon activa-
tion of caspase-1econtaining protein complexes, called
inﬂammasomes.3 Inﬂammasome activation was shown to
be involved in neointima formation after vascular injury.4,5
Furthermore, cholesterol crystal deposition appears to
act as an endogenous danger signal. In inﬁltrating
macrophages, the crystals activate a nucleotide-binding
oligomerization domain (NOD)-like receptor family,
pyrin domain-containing 3 (NLRP3) inﬂammasome,
which is required for atherogenesis.6,7 Besides inﬁltrating
inﬂammatory cells, endothelial cells (ECs) and vascular
smooth muscle cells (VSMCs) appear to respond with
molecular defense mechanisms to mechanical and physio-
logic stress. In particular, inducible expression of Toll-like
receptors and endogenous pathogen-associated pattern
recognition receptors has been detected in vascular endo-
thelium in response to injury, resulting in activation of
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IL-1b and IL-18.8
Recently, absent in melanoma 2 (AIM2) was identiﬁed
as a novel inﬂammasome-activating protein that acts as
a cytosolic DNA sensor in macrophages.9-12 AIM2 belongs
to the HIN200 family of hematopoietic, interferon (IFN)-
inducible, nuclear proteins and appears to be essential for
host defense against DNA viruses and certain cytosolic
bacteria.13-16 In addition, we and others demonstrated
a role of AIM2 in tumor pathology.17-20 AIM2 is fre-
quently affected by genetic and epigenetic alterations in
different human tumor entities.18,21,22 Moreover, overex-
pression or induction of AIM2 by IFN-g in tumor cells
resulted in reduced cell proliferation, increased cell migra-
tion,19 and induction of IFN-gestimulated target genes.20
The role of AIM2 in nonmyeloid vascular cells, however,
has not yet been investigated.
Given the above-described role of inﬂammasomes in
vascular dysfunction and our previous ﬁndings in tumor
cells, we assumed that AIM2 might likewise act as a poten-
tial damage receptor for vascular injury. We thus addressed
AIM2 expression in healthy arterial wall and in different
arterial lesions with respect to cellular origin, expression
intensity, and intraplaque localization. Moreover, AIM2
expression was characterized in cultured human aortic
ECs and VSMCs in response to proinﬂammatory cytokines
and cytoplasmic DNA.
METHODS
All tissues used in this study were collected and pro-
cessed according to ethical guidelines. The University of
Heidelberg Medical Ethics Committee approved this
study. All patients gave their written informed consent.
Tissues. Four aortic artery and 20 carotid artery
lesions from patients undergoing surgery were randomly
selected from the vascular tissue bank of the Department
of Vascular Surgery, Heidelberg, Germany. Normal
vascular tissue derived from cadaveric donors was obtained
from the tissue bank of the National Centre for Tumor
Disease (NCT-Gewebebank Heidelberg). Basic demo-
graphic and clinical data of patients are listed in the
Supplementary Table (online only).
Tissue processing. Carotid artery plaques from
patients undergoing carotid endarterectomy were obtained
by dissection of the internal carotid artery from the bifurca-
tion and harvesting by the vascular surgeon (routine ever-
sion technique). Indications for carotid endarterectomy
were high-grade internal carotid artery stenosis (as deter-
mined by ultrasound imaging), transient ischemic attack,
amaurosis fugax, or ischemic stroke. Aortic tissue samples
were harvested by the vascular surgeon from patients
undergoing open infrarenal aortic aneurysm repair after
proximal aortic cross-clamping. Indication for infrarenal
aortic aneurysm repair was a maximum aneurysm diameter
of >50 mm and exclusion from endovascular repair.
Four aortic samples showing signs of atherosclerosis,
such as cholesterol inclusion and calciﬁcation, were chosen
for analysis. Samples were immediately rinsed with saline toremove surface blood and divided into two tissue blocks,
one for formalin ﬁxation and a second for shock freezing
in liquid nitrogen and cryoconservation at 80C.
Cell culture. Primary human aortic ECs (HAoECs)
and smooth muscle cells (HAoSMCs) were purchased
from PromoCell (Heidelberg, Germany). Cells were grown
in Endothelial Cell Growth Medium MV, supplemented
with Endothelial Cell Supplement Mix or in Smooth
Muscle Cell Growth Medium (PromoCell), respectively.
The HAo-VSMC cell line T/G HA-VSMC (LGC Stan-
dards, Wesel Germany) was cultivated in human VSMC
medium 231 supplemented with SMGS (Life Technolo-
gies, Darmstadt, Germany). Subcultures were obtained
every 2 or 3 days by using DetachKit-125 (PromoCell) for
ﬁve passages (HAoECs and HAoSMCs) or longer (T/G
HA-VCMCs). For stimulation, cells were seeded in 6-well
plates at a density of 106 cells/well and 100 U/mL
recombinant human IFN-g (R&D Systems, Wiesbaden-
Nordenstadt, Germany), 25 ng/mL recombinant
human TNF-a (R&D Systems) or 1 mg/mL poly(dA:dT)
(poly(dA:dT)/LyoVec, InVivo) was added to the media
for 6 to 96 hours, as indicated in Figs 1 and 2.
The timing and dosage of stimulation with cytokines
that were chosen for analysis of AIM2 expression had
been previously investigated in tumor cells.20 Treatment of
the cells with the indicated dosages progressively reduced
proliferation and resulted in cellular senescence after 96
hours (Lee et al20 and unpublished data). The amount
of poly(dA:dT) was optimized in preliminary experiments
(Supplementary Fig 1, online only). Stimulation was
repeated every 48 hours by replacement of the media
and addition of fresh cytokines. Independent of the stim-
ulation period, all cells were grown for 96 hours on
6-well plates before harvesting for RNA extraction or lysis
in radioimmunoprecipitation assay buffer (see below).
The monocyte cell line THP-1 was grown in Roswell
Park Memorial Institute-1640 cell culture medium, supple-
mented with 10% fetal calf serum, 2 mM L-glutamine, and
antibiotics. To induce differentiation, cells were treatedwith
300 ng/mL phorbol 12-myristate 13-acetate (Sigma-
Aldrich, Taufkirchen, Germany) for 3 hours, washed in
phosphate-buffered saline, grown for 3 days, and trans-
fected overnight with 1 mg poly(dA:dT).
Immunohistochemistry. Tissues were formalin-ﬁxed
and embedded in parafﬁn in transversal orientation ac-
cording to standard procedures for conventional histo-
logic analysis. For immunohistochemical detection of
protein expression, serial 4-mm sections were prepared
from each parafﬁn-embedded tissue specimen. After
parafﬁn was removed and samples were rehydrated, they
were pretreated according to individually optimized
protocols (detailed protocols are available on request).
The primary antibodies used for detection were polyclonal
rabbit anti-AIM2 (dilution 1:150; Sigma, Taufkirchen,
Germany), monoclonal mouse anti-SMA (clone 1A4;
dilution 1:1000; DAKO, Glostrup, Denmark), mono-
clonal mouse anti-CD68 (clone PG-M1; dilution 1:1000,
DAKO), and monoclonal mouse anti-CD31 (clone 89C2;
Fig 1. Absent in melanoma 2 (AIM2) transcript expression in human aortic endothelial and smooth muscle cells in
response to inﬂammatory cytokines illustrating the time-dependent induction of AIM2 in each of the cell types.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression of corresponding samples is shown for control to
demonstrate that equal amounts of total complementary DNA were analyzed, independent of cell viability. A, End-
point reverse-transcription polymerase chain reaction of tumor necrosis factor (TNF)-aestimulated (upper panel)
and interferon (IFN)-gestimulated (lower panel) human aortic endothelial cells (HAoEC), smooth muscle cells
(HAoSMC), and in the aortic vascular smooth muscle cell line (T/G-HA-VSMC). B, Quantitative real-time reverse
transcription polymerase chain reaction of the same cells as in A. Fold-AIM2 expression is shown relative to expression
of 18s RNA in corresponding samples. The bars and error bars represent the mean and standard deviation, respectively,
of triplicate analysis. *P < .05; **P < .01 (paired t-test) 0*: cells were grown without media replacement for 96 hours.
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Fig 2. Expression of (A) absent in melanoma 2 (AIM2) transcript and (B) protein in human aortic smooth muscle
cells (HAoSMC) upon stimulation with foreign double-stranded DNA (poly(dA:dT)) with or without previous
stimulation with interferon (IFN)-g. A, Little AIM2 expression is detected in unstimulated cells, which is markedly
upregulated upon transfection of the cells with poly(dA:dT) and pretreatment of the cells with IFN-g. B,
The inﬂammasome component ASC is expressed in HAoSMC and in the aortic vascular smooth muscle cell line
(T/G-HA-VSMC) at levels that are not affected by cytoplasmic double-stranded DNA or IFN-g. AIM2 protein
expression is below detection level in HAoSMC and T/G-HA-VSMC.
JOURNAL OF VASCULAR SURGERY
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Biolabs, Frankfurt, Germany).
RNA extraction, complementary DNA synthesis,
and polymerase chain reaction analysis. RNA was
extracted from indicated cell lines using theRNeasyKit (Qia-
gen, Hilden, Germany). For complementary (c)DNA
synthesis, 1 mg total RNA from each sample was reverse-
transcribed using oligo-dT primers and SuperScript II
reverse transcriptase (Invitrogen Life Technologies, Karls-
ruhe, Germany), following the manufacturer’s instructions.
End-point polymerase chain reaction (PCR) was performed
as previously described18 by using the following primers:
AIM2: 50-AGCTGACATCTGGAGTTCATAGC-30
and 50-CTGCTTAGACCAGTTGGCTTG-30;
GAPDH: 50-GGCTGCTTTTAACTCTGGTA-30
and 50-CTTGACGGTGCCATGGAATT-30.
For real-time PCR, PowerSYBR Green Master Mix
(Applied Biosystems, Darmstadt, Germany) was added to
appropriate cDNA samples and primers:
AIM2: 50-CATCTGCAGCCATCAGAA-30 and
50-CGCTTCTGAAACCCTTCTCT-30;
18s RNA: 50-AAACGGCTACCACATCCAAG-30
and 50-CCTCCAATGGATCCTCGTTA-30.Samples were loaded onto 96-well PCR plates and
analyzed in an ABI Prism 7300 thermocycler (Applied Bio-
systems), as described.20 Quantitative analysis of gene
expression was performed relative to expression of 18s
RNA in corresponding samples by using individual stan-
dard ampliﬁcation curves of each transcript.
Immunoblotting. Cells were harvested on ice in
radioimmunoprecipitation assay cell lysis buffer (50 mM
TRIS-HCl [pH 7.5], 150 mM NaCl, 0.5% sodium deox-
ycholate, 0.1% sodium dodecyl sulfate, 0.5% NP-40) supple-
mented with protease inhibitor (Mix G, Serva, Heidelberg,
Germany). Equal amounts of protein (20-30 mg per lane)
were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, blotted on nitrocellulose, and visual-
ized by chemoluminescence, as described.20 The following
antibodies and dilutions were applied for detection: rabbit
polyclonal anti-AIM2 (ab93015, dilution 1:500; Abcam,
Cambridge,UnitedKingdom), antiactin (cloneC4, dilution
1:5000; MP Biomedicals, Aurora Ohio), and rabbit poly-
clonal anti-ASC (dilution 1:1000; Enzo Life Sciences,
Lörrach, Germany).
RESULTS
AIM2 is differentially expressed in healthy and
diseased arterial wall. We initially investigated the AIM2
expression pattern in normal vs diseased human arterial
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plaques and arterial tissue from abdominal aortic aneu-
rysms) to receive an impression about its localization and
cell afﬁliation. By immunohistochemical analysis using
thoroughly characterized antibodies (Supplementary
Fig 2, online only), we found basic AIM2 expression in
intact, nonatherosclerotic intima and media from the
internal carotid artery and the aorta (representative exam-
ples in Fig 3, A and B). In addition, AIM2 expression was
detected in CD31-positive, as well as in smooth muscle
actin (SMA)-positive cells of normal vasa vasorum, indi-
cating that EC and VSMC can both endogenously express
AIM2 in situ (Fig 3, A and B).
In contrast, the AIM2 expression pattern was more
complex in vascular lesions. Three of four abdominal
aortic aneurysms displayed increased AIM2 expression in
SMA-positive cells of intima/media and vasa vasorum/
neovascular cells, suggesting that it is upregulated in
VSMC in these lesions compared with intact aortic wall
(Fig 4, A, lesions 1-3). Surprisingly, AIM2 expression was
absent in the SMA-positive intima/media of one aortic
lesion (Fig 4, A, aortic lesion 4). In 16 of 20 atheroscle-
rotic carotid lesions, a particularly high AIM2 expression
was found around the necrotic core of the plaque (repre-
sentative examples in Fig 4, B), where it overlapped with
expression of SMA and CD68. The latter identiﬁes
macrophages inﬁltrating the lesion, which suggests that
at least some of the AIM2-positive cells represent inﬂam-
matory cells.
AIM2 expression in cultured HAoECs and
HAoSMCs is induced by TNF-a and IFN-g. To further
elucidate the identity of AIM2 expressing cells, we
analyzed cultured primary HAoECs, primary HAoSMCs,
and the T/G HA-VSMC cell line in vitro and investi-
gated their capacity to respond to the proinﬂammatory
cytokines TNF-a and IFN-g. The rationale behind this
stimulation was to test our hypothesis that cytokines
released from inﬂammatory cells activate AIM2 or even an
inﬂammasome in macrovascular nonmyeloid cells of larger
arteries, thus provoking an intracellular damage response.
Aberrant production of TNF-a and IFN-g by activated
macrophages and T cells, respectively, has been asso-
ciated with several inﬂammatory diseases, including
atherosclerosis.23,24
We here detected basic AIM2 transcript expression
in unstimulated primary aortic cells (HAoECs and
HAoSMCs), whereas it was very low to absent in the T/G
HA-VSMC cell line (Fig 1, A). Stimulation of the cells
with TNF-a or IFN-g resulted in a time-dependent
upregulation of AIM2 expression in each of the cell
types (Fig 1, A), although induction by TNF-a was only
weak in T/G HA-VSMC cultures (Fig 1, A, upper right
panel). Quantitative analysis by real-time PCR revealed
a maximum of up to 100-fold induction of AIM2 transcript
expression inHAoEC andHAoSMCcultures and 22-fold in
T/G-HA-VSMC cultures in response to IFN-g (Fig 1, B,
lower panel), whereas induction by TNF-a was less intense
(Fig 1, B, upper panel).To determine AIM2 protein expression, we next per-
formed Western blot analysis of untreated and cytokine-
stimulated cultured aortic cells. The 39-kD AIM2 protein
monomer was clearly upregulated in HAoEC cultures by
TNF-a and IFN-g compared with untreated HAoEC
cultures (Fig 5, A). The maximum expression level was
observed after 6 and 24 hours of treatment, respectively,
and declined to the initial basic level during longer treat-
ment (Fig 5, A), despite continuous replacement of media
and cytokines every 48 hours. This suggests that AIM2
induction is an early, transient event in HAoECs. In
contrast to HAoECs, AIM2 protein expression was hardly
detectable in TNF-a and IFN-gestimulated primary
HAoSMCs and remained below detection level in T/G-
HA-VSMCs (Fig 5, B and C).
Cytosolic double-stranded DNA induces AIM2
transcript expression in cultured HAoSMCs. In addi-
tion to its role in macrophages, AIM2 was recently shown
to be induced by cytosolic double-stranded (ds)DNA
likewise in nonmyeloid cells, such as keratinocytes.25,26
Upon induction, AIM2 here triggered inﬂammasome
activation and caspase-1edependent release of activated
IL-1b. We therefore investigated whether AIM2 inﬂam-
masomes may likewise be activated by dsDNA in VSMCs.
Transfection of the cells with poly(dA:dT) clearly induced
AIM2 transcript expression in HAoSMC and T/G-
HA-VSMC cultures (Fig 2, A). Moreover, pretreatment
of the cells with 100 U/mL IFN-g for 6 hours resulted in
an additional upregulation of poly(dA:dT)-induced AIM2
transcript expression in HAoSMC and T/G HA-VSMC
cultures (Fig 2, A).
To further determine activation of an AIM2 inﬂamma-
some in SMC cultures, whole cell lysates treated as
described with IFN-g or poly(dA:dT), or both, were sub-
jected to Western blot analysis for detection of several
inﬂammasome components. Despite clear detection of
the AIM2 protein in SMC in situ (Fig 3, A), it remained
below detection level in cultured SMC, even upon stimula-
tion (Fig 2, B). The adaptive protein apoptosis-associated
speck-like protein containing CARD (ASC), which is
required in macrophages for activation of the AIM2 inﬂam-
masome,9 was detected in HAoSMC and T/G-HA-VSMC
cultures at levels that were independent from stimulation
with IFN-g or poly(dA:dT), or both (Fig 2, B). However,
in contrast to the ﬁndings in macrophages and keratino-
cytes, activation of caspase-1 and IL-1b could not be
demonstrated in VSMCs, neither in response to IFN-g or
TNF-a nor in response to poly(dA:dT) (data not shown).
Thus, VSMCs respond to foreign cytoplasmic DNA with
upregulation of AIM2 expression potentially without trig-
gering caspase-1 activation.
DISCUSSION
This study characterized AIM2 expression in human
nonmyeloid vascular cells and lesions of different entities
and provides evidence for its role in vascular inﬂammation
and atherogenesis. The AIM2 protein was immunohisto-
chemically detected in human vascular cells of healthy
Fig 3. Absent in melanoma 2 (AIM2) expression pattern is shown in human arterial wall. Formalin-ﬁxed parafﬁn-
embedded sections were immunohistochemically stained for AIM2, CD31, and smooth muscle actin (SMA).
A, Normal, nonatherosclerotic carotid artery. B, Normal, nonatherosclerotic aorta. Ad, Adventitia; EC, endothelial
cells; I, intima; M, media. Original magniﬁcation, 4, 10, or 200, respectively, as indicated. Examples from 10
normal arterial samples are shown, with red indicating positive immunostaining and blue indicating nuclei and
connective tissue.
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Fig 4. Absent in melanoma 2 (AIM2) expression pattern is shown in lesions derived from (A) abdominal aortic
aneurism (AAA) and (B) atherosclerotic carotid artery. A, AIM2 expression is increased in smooth muscle actin (SMA)-
positive cells of the intima/media (lesion 1) and of the vasa vasorum (lesions 2 and 3; adventitia) of AAA, whereas it is
absent in the SMA-positive intima/media of lesion 4. B, Atherosclerotic carotid lesions show that AIM2 expression
accumulates in cells surrounding necrotic and calciﬁed (**) areas or cholesterol (Ch) within the intima/media.
Examples of four AAA samples and 20 atherosclerotic carotid samples are shown, with red indicating positive
immunostaining and blue indicating nuclei and connective tissue. Original magniﬁcation, 100.
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Fig 5. Western blot analysis for absent in melanoma 2 (AIM2) protein expression in (A) primary human aortic
endothelial cells (HAoEC), (B) primary human aortic smooth muscle cells (HAoSMC), and (C) the aortic vascular
smooth muscle cell line (T/G-HA-VSMC). Cells were analyzed in response to the inﬂammatory cytokines tumor
necrosis factor (TNF)-a and interferon (IFN)-g. Lysates were derived from cells stimulated in parallel to the cells used
in Fig 1. Differentiated THP-1 cells were transfected with poly(dA:dT), as described in the Methods section, and used
as a positive control. Protein loading was assessed by actin expression.
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ﬂammatory cytokines TNF-a and IFN-g as well as dsDNA
were identiﬁed as triggers to stimulate AIM2 expression in
aortic ECs and VSMCs, respectively. This is the ﬁrst report
demonstrating that ECs and VSMCs can respond to these
proinﬂammatory stimuli by elevating AIM2 expression.
The precise role of AIM2 in vascular cells, however, is
not yet clear.
Similar to other nonmyeloid cells, such as keratino-
cytes25,26 and certain tumor cells,27 aortic ECs and VSMCs
might express AIM2 as a component of inﬂammasomes.
Inﬂammasomes are multiprotein complexes that can pro-
teolytically activate caspase-1 and caspase-5, which results
in release of IL-1b and a subsequent form of cell death,
called pyroptosis. Their activity is regulated by expressionof several proteins, including NLRP3, NLRC4, NLRP6,
and AIM2, which act as sensors for microbial infection or
cellular damage.3 Induction of an AIM2 inﬂammasome
resulting in caspase-1edependent inﬂammatory response
and release of IL-1b was originally shown to be important
for pathogen defense by macrophages.28,29 Moreover,
NLRP3 inﬂammasomes have been demonstrated to be
activated by endogenous cholesterol crystals in plaque
inﬁltrating macrophages of atherosclerotic lesions.6,7
Our data add to these ﬁndings by identifying AIM2 induc-
tion in aortic ECs and VSMCs in response to proinﬂamma-
tory stimuli, which suggests its potential participation in
inﬂammasome activation in these cell types.
ECs have been previously analyzed for activation of
inﬂammasome components upon stimulation with TNF-a.8
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of NOD-like receptor family, pryrin domain-containing 1
(NLRP1) and IL-1b in human umbilical vein endothelial
cells (HUVECs) treated with TNF-a for 6 hours.
Furthermore, induction of several Toll-like receptor
genes (TLR1, TLR3, TLR6, and TLR7) was detected,
whereas NLRP3, Caspase-1, or Caspase-5, the character-
istic inﬂammasome components of macrophages inﬁl-
trating atherosclerotic lesions, were not induced.8
On the basis of their data, the authors suggested that
in principle, upregulation of certain inﬂammasome-
related gene expression is modulated by inﬂammatory
signals in ECs; however, they state that future work on
that is needed in additional vascular cell types and in
response to further stimuli.8 Our ﬁndings support this
idea by demonstrating induction of AIM2 in TNF-ae
and IFN-gestimulated HAoECs. Moreover, we recently
identiﬁed transcript expression of additional inﬂamma-
some components in HAoECs, including ASC, Pro-IL-1b,
CASP1, and CASP5 (data will be published elsewhere).
However, activation of these components on the protein
level and their functional role in association with AIM2
remain to be investigated. We thus cannot yet conclude
from our data whether an inﬂammasome is activated in
aortic ECs stimulated by TNF-a or IFN-g.
Alternatively, AIM2 may be involved in activation of
other intracellular inﬂammatory pathways in this cell type.
Interestingly, we had previously demonstrated upregula-
tion of TLR3 and several IFN-stimulated genes (ISGs) in
AIM2 transfected cancer cells.20 Our ongoing investiga-
tions will illustrate whether ISGs or other inﬂammatory
response genes are likewise induced in aortic ECs upon
induction of AIM2.
Finally, IFN-g stimulation of ECs is known to enhance
EC-leukocyte adherence and class 2 antigen presentation
by ECs (ie, in response to infection of the endothelium
by pathogens).30 Consequently, the IFN-gestimulated
induction of AIM2 in aortic ECs identiﬁed here may alter-
natively mediate this effect. Our recent ﬁndings demon-
strating that AIM2 overexpression results in upregulation
of human leukocyte antigen class II and of several genes
involved in intercellular adhesion20 are in line with this
hypothesis. However, whether AIM2 overexpression like-
wise mediates induction of these genes in aortic ECs
remains to be determined.
Numerous reports have described the response of
VSMCs to the proinﬂammatory cytokines TNF-a and
IFN-g, which involves induction of gene expression and
de novo protein synthesis that induces new effector func-
tions.31 We here observed a slightly different time course
of AIM2 induction between two aortic SMC cultures,
HAoSMCs and T/G-HA-VSMCs. The reason for this
discrepancy might be the origin of the two cell types.
HAoSMCs are primary aortic cells derived from an 84-
year-old donor (PromoCell, certiﬁcate of analysis). They
undergo 10 to 15 doublings and can be passaged ﬁve to
six times in culture before they stop proliferation and go
into a senescent status. In contrast, T/G-HA-VSMC isa normal human aortic cell line from an 11-month-old
donor, which may undergo 35 doublings before senes-
cence (LGC standards, product description). The response
to cytokines and upregulation of AIM2 is possibly differen-
tially regulated according to cell age.
Little is known about inﬂammasome or IL-1b activa-
tion, or both, in VSMCs. Induction of the NLRP3 and
IL-1b genes was recently reported to occur in TNF-ae
stimulated aortic VSMCs, indicating a role of the NLRP3
inﬂammasome in these cells.32 In addition, increased tran-
script expression of caspase-1 (also known as interleukin-
1beconverting enzyme), was reported to induce cell death
of VSMCs.33 Our data, demonstrating constitutive expres-
sion of ASC, in combination with dsDNA-/IFN-ge
stimulated induction of AIM2 expression in VSMCs are
in line with the hypothesis of an AIM2 inﬂammasome in
VSMCs. However, as with aortic ECs, we cannot conclude
from our data whether an inﬂammasome is activated in
TNF-ae or IFN-gestimulated aortic VSMCs. Although
AIM2 protein was detected in healthy media of carotid
and aortic arteries and vasa vasorum, it remained below
the detection level in cultured dsDNA-/IFN-gestimulated
VSMC, despite a clear induction of AIM2 transcript
expression. Moreover, neither a proteolytic activation of
caspase-1 nor of IL-1b was detectable in dsDNA-/IFN-ge
stimulated VSMCs, although the primary HAoSMCs and
the T/G-HA-VSMC cell line do express ASC, CASP1,
CASP5, and Pro-IL-1b transcripts (data will be published
elsewhere). The reason for the discrepancy between
AIM2 protein expression in situ and in vitro is not clear.
Endogenous AIM2 is known to be expressed at very low
levels and to be rather unstable (personal communication
to S.D.), which might result in fast degradation in protein
lysates derived from cell cultures.
Alternatively, AIM2 expression might result in activa-
tion of other inﬂammatory pathways in VSMCs. IFN-g
stimulation has previously been shown to induce major
histocompatibility class II transactivator (CIITA) isoforms
III and IV in aortic VSMCs, resulting in activation of
HLA II protein.34 As mentioned above, this is in line
with our previous observation demonstrating that AIM2
can mediate upregulation of HLA class II and CIITA iso-
form IV.20 Our future investigation, using AIM2/ and
other mouse models of enhanced vascular inﬂammation
will help to elucidate the precise role of AIM2 in VSMCs
and explore if it has a causal linkage with atherosclerosis or
other vascular pathologies that are associated with chronic
inﬂammation.CONCLUSIONS
The AIM2 expression pattern in macrovascular ECs and
VSMCs identiﬁed here and its upregulation in response to
the most prominent proinﬂammatory cytokines involved in
atherosclerosis suggest a functional involvement of AIM2
in vascular pathogenesis. These ﬁndings provide new insight
on the molecular mechanisms of vascular inﬂammation
beyond the role of AIM2 and inﬂammasomes in
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 3 Hakimi et al 803macrophages, and thus widen the range of putative prog-
nostic and/or therapeutic targets in atherosclerosis.
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Supplementary Fig 1 (online only). Induction absent in melanoma 2 (AIM2) transcript expression by cytoplasmic
DNA in HT-29 colorectal cancer cells. Reverse transcription polymerase chain reaction was performed as described
earlier.18 GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; IFN, interferon.
Supplementary Fig 2 (online only). Characterization of anti-absent in melanoma 2 (AIM2) antibody for immu-
nohistochemical analysis. A, For characterization of AIM2 detection by the anti-AIM2 antibody, 293T cells were
transfected with empty enhanced green ﬂuorescent protein (EGFP) vector or a plasmid encoding EGFP-AIM2-fusion
protein. Cells were formalin-ﬁxed, precipitated in bovine serum albumin, and embedded in parafﬁn according to
standard procedures. Immunohistochemistry was performed as described in the Methods section. Dilution of anti-
AIM2: 1:150. B, Detection of AIM2 in single cells of a lymph node. Dilution of anti-AIM2: 1:150. C, Detection
of AIM2 in normal small intestinal epithelium. Strong cytoplasmic expression of AIM2 is detectable in epithelial cells
lining the lumen. Dilution of anti-AIM2: 1:150. Original magniﬁcation 40 or 200, as indicated.
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Supplementary Table (online only). Sample characteristics and demographic data of patients and donors
Sample ID Diagnosis Age (years) Sex Diabetic Nicotine abuse AIM2 around necrotic core
Carotid lesion
1 Stenosis; sy 78 M N Y Y
2 Stenosis; sy 81 M N N Y
3 Stenosis; sy 61 F Y N Y
4 Stenosis; as 74 F Y N N/A
5 Stenosis; sy 49 M N Y Y
6 Stenosis; as 55 M N N Y
7 Stenosis; as 75 F Y N N/A
8 Stenosis; as 58 M Y N Y
9 Stenosis; as 75 F N Y Y
10 Stenosis; as 79 M N N Y
11 Stenosis; as 64 F N Y Y
12 Stenosis; sy 84 M Y N Y
13 Stenosis; sy 50 F Y N Y
14 Stenosis; as 77 M Y Y Y
15 Stenosis; sy 64 M Y N Y
16 Stenosis; as 76 M Y N N/A
17 Stenosis; as 71 M N Y Y
18 Stenosis; as 57 F N N Y
19 Stenosis; sy 76 M Y Unknown N/A
20 Stenosis; as 70 M Y Y Y
Control Normal 55 M Unknown Unknown N/A
Aortic lesion
1 AAA 78 M N N N/A
2 AAA 84 M N N N/A
3 AAA 78 M N N N/A
4 AAA 69 M N N N/A
Control Normal 45 M Unknown Unknown N/A
AAA, Abdominal aortic aneurysm; AIM2, absent in melanoma 2; as, asymptomatic; F, female; M, male; N, no (never); N/A, not applicable; sy, symptomatic;
Y, yes (ever).
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